| Announce Date | 10/24/2025 |
| EPS Normalized Actual | $1.42 (Miss by $-0.07) |
| EPS GAAP Actual | $1.42 (Miss by $-0.07) |
| Revenue Actual | $2.89B |
| Revenue Surprise | Beat by $2890M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.75418 |
| EPS GAAP Estimate | $1.75418 |
| Revenue Estimate | $3.167340333B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2028 | 8.65 | 10.11 | 8.4297 | 8.94172 | 1 |
| Mar 2027 | 5.752 | 15.21 | 5.40623 | 6.01303 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.42 | -0.23655 | 2.89B | -8.87% | -238.95M |
| FQ2 2025 (Jun 2025) | 2.17 | 0.44689 | 2.924B | -0.61% | -79.52M |
| FQ1 2025 (Mar 2025) | 1.52 | 1.52 | 2.97463B | 6.83% | 2974.63M |
| FQ4 2024 (Dec 2024) | 1.48 | 1.48 | 2.91719B | 11.91% | 2917.19M |
| FQ3 2024 (Sep 2024) | 3.02 | 3.02 | 3.14639B | 15.26% | 3146.39M |
| FQ2 2024 (Jun 2024) | 1.27 | 1.27 | 2.9418B | 9.77% | 2941.8M |
| FQ1 2024 (Mar 2024) | 0.98 | 0.98 | 2.77133B | 12.2% | 2771.33M |
| FQ4 2023 (Dec 2023) | 1.11 | 1.11 | 2.5698B | 11.39% | 2569.8M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.75418
Consensus Revenue Estimates
3.167340333B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 2.01722 | -- | 1.93125 | 2.1183 | 6 |
| FQ4 2027 (Dec 2027) | 2.14826 | -- | 2.05671 | 2.25591 | 5 |
| FQ3 2027 (Sep 2027) | 2.07123 | -- | 1.99291 | 2.16871 | 8 |
| FQ2 2027 (Jun 2027) | 1.99937 | -- | 1.92377 | 2.09347 | 5 |
| FQ1 2027 (Mar 2027) | 1.83457 | -- | 1.79243 | 1.87797 | 3 |
| FQ4 2026 (Dec 2026) | 1.90262 | -- | 1.85892 | 1.94763 | 4 |
| FQ3 2026 (Sep 2026) | 2.0066 | 29.23 | 1.96051 | 2.05407 | 3 |
| FQ2 2026 (Jun 2026) | 1.94207 | -11.74 | 1.89746 | 1.98801 | 4 |
| FQ1 2026 (Mar 2026) | 1.52072 | 0.05 | 1.48236 | 1.55623 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 3.46B | -- | 3.35B | 3.6B | 5 |
| FQ4 2027 (Dec 2027) | 3.34B | -- | 3.23B | 3.47B | 6 |
| FQ3 2027 (Sep 2027) | 3.34B | -- | 3.24B | 3.46B | 5 |
| FQ2 2027 (Jun 2027) | 3.3B | -- | 3.2B | 3.42B | 5 |
| FQ1 2027 (Mar 2027) | 3.43B | -- | 3.37B | 3.49B | 3 |
| FQ4 2026 (Dec 2026) | 3.22B | -- | 3.17B | 3.28B | 3 |
| FQ3 2026 (Sep 2026) | 3.44B | 15.96 | 3.38B | 3.5B | 3 |
| FQ2 2026 (Jun 2026) | 3.42B | 14.42 | 3.36B | 3.48B | 4 |
| FQ1 2026 (Mar 2026) | 3.05B | 2.31 | 2.99B | 3.1B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.65655 | 1.42 | -0.23655 | -16.66% |
| FQ2 2025 (Jun 2025) | 1.72311 | 2.17 | 0.44689 | 20.59% |
| FQ1 2025 (Mar 2025) | 1.52 | 1.52 | 100% | |
| FQ4 2024 (Dec 2024) | 1.48 | 1.48 | 100% | |
| FQ3 2024 (Sep 2024) | 3.02 | 3.02 | 100% | |
| FQ2 2024 (Jun 2024) | 1.27 | 1.27 | 100% | |
| FQ1 2024 (Mar 2024) | 0.98 | 0.98 | 100% | |
| FQ4 2023 (Dec 2023) | 1.11 | 1.11 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $3.13B | $2.89B | $-238.95M | -8.27% |
| FQ2 2025 (Jun 2025) | $3B | $2.92B | $-79.52M | -2.72% |
| FQ1 2025 (Mar 2025) | $0B | $2.97B | $2974.63M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.92B | $2917.19M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $3.15B | $3146.39M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.94B | $2941.8M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.77B | $2771.33M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.57B | $2569.8M | 100% |